Table of Contents
What if a simple blood test at your annual physical could detect cancer in its earliest stages?
Dr. Helmy Eltoukhy, co-founder and co-CEO of Guardant Health, is turning this vision into reality. They’ve seen a spate of FDA approvals. With groundbreaking technologies like Guardant360 and Shield, they're revolutionizing cancer detection and treatment.
I had the pleasure of catching up with Helmy at JPM Week 2025, where he explained how Guardant are leveraging genomics to identify cancer signals in the blood, before symptoms even appear. I hope you enjoy watching!
Yours sincerely,
Dr. Adil Ali
